Work

Pcv49 Cost-effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Portuguese Patients

Year: 2019

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2019.09.774

Authors: F. de Andrés-Nogales, P.R. Gay-Pobes, M. Inês, C. Polanco Sánchez, D. Alves, I. Oyagüez

Institutions: Pharmacoeconomics and Health Outcomes Research Iberia (Spain), Pfizer (Portugal), Bristol-Myers Squibb (Portugal)

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4240769816

Cites:

Cited by:

Related to: 10